ADJUVANT AUTOLOGOUS INTRAVESICAL MACROPHAGE CELL THERAPY VS. BCG FOR NON-MUSCLE INVASIVE BLADDER CANCER: A PHASE II, MULTICENTER, RANDOMIZED TRIAL

被引：0
|
作者：
Burger, M. [1 ]
Thiounn, N. [2 ]
Denzinger, N. [1 ]
Malavaud, B. [3 ]
Wirth, M. [4 ]
Thueroff, J. W. [5 ]
Romics, I. [6 ]
Colombel, M. [7 ]
Solsona, E. [8 ]
Tombal, B. [9 ]
Sherman, J. [10 ]
机构：
[1] Univ Regensburg, Dept Urol, Regensburg, Germany
[2] Univ Paris 05, Dept Urol, Paris, France
[3] Paris St Joseph Hosp Trust, Dept Urol, Paris, France
[4] Univ Dresden, Dept Urol, Dresden, Germany
[5] Johannes Gutenberg Univ Mainz, Dept Urol, Mainz, Germany
[6] Semmelweis Univ, Dept Urol, H-1085 Budapest, Hungary
[7] Hop Edouard Herriot, Dept Urol, Lyon, France
[8] Inst Valenciano Oncol, Dept Urol, Valencia, Spain
[9] Clin Univ St Luc, Dept Urol, B-1200 Brussels, Belgium
[10] IDM Pharma, Dept Med, Irvine, CA USA
来源：
EUROPEAN UROLOGY SUPPLEMENTS | 2009年 / 8卷 / 04期
关键词：
D O I：
10.1016/S1569-9056(09)60652-7
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：285 / 285
页数：1
相关论文
共 50 条
  • [31] Study protocol of a phase II clinical trial of oral metformin for the intravesical treatment of non-muscle invasive bladder cancer
    Remco J. Molenaar
    Jons W. van Hattum
    Iris S. Brummelhuis
    Jorg R. Oddens
    C. Dilara Savci-Heijink
    Egbert R. Boevé
    Saskia A. van der Meer
    J. Fred Witjes
    Michael N. Pollak
    Theo M. de Reijke
    Johanna W. Wilmink
    BMC Cancer, 19
  • [32] Study protocol of a phase II clinical trial of oral metformin for the intravesical treatment of non-muscle invasive bladder cancer
    Molenaar, Remco J.
    van Hattum, Jons W.
    Brummelhuis, Iris S.
    Oddens, Jorg R.
    Savci-Heijink, C. Dilara
    Boeve, Egbert R.
    van der Meer, Saskia A.
    Witjes, J. Fred
    Pollak, Michael N.
    de Reijke, Theo M.
    Wilmink, Johanna W.
    BMC CANCER, 2019, 19 (01)
  • [33] Compared Efficacy of Adjuvant Intravesical BCG-TICE vs. BCG-RIVM for High-Risk Non-Muscle Invasive Bladder Cancer (NMIBC): A Propensity Score Matched Analysis
    Del Giudice, Francesco
    Flammia, Rocco Simone
    Chung, Benjamin I.
    Moschini, Marco
    Pradere, Benjamin
    Mari, Andrea
    Soria, Francesco
    Albisinni, Simone
    Krajewski, Wojciech
    Szydelko, Tomasz
    Laukhtina, Ekaterina
    D'Andrea, David
    Gallioli, Andrea
    Mertens, Laura S.
    Maggi, Martina
    Sciarra, Alessandro
    Salciccia, Stefano
    Ferro, Matteo
    Scornajenghi, Carlo Maria
    Asero, Vincenzo
    Cattarino, Susanna
    De Angelis, Mario
    Cacciamani, Giovanni E.
    Autorino, Riccardo
    Pandolfo, Savio Domenico
    Falagario, Ugo Giovanni
    D'Altilia, Nicola
    Mancini, Vito
    Chirico, Marco
    Cinelli, Francesco
    Bettocchi, Carlo
    Cormio, Luigi
    Carrieri, Giuseppe
    De Berardinis, Ettore
    Busetto, Gian Maria
    CANCERS, 2022, 14 (04)
  • [34] Analysis of inflammatory response during intravesical immunotherapy with BCG for non-muscle invasive bladder cancer
    Takeda, Yuji
    Kato, Tomoyuki
    Naito, Sei
    Ito, Hiromi
    Ushijima, Masaki
    Narisawa, Takafumi
    Kanno, Hidenori
    Kurota, Yuta
    Tsuchiya, Norihiko
    Asao, Hironobu
    CANCER SCIENCE, 2021, 112 : 841 - 841
  • [35] Chest wall tumor following intravesical BCG instillation for non-muscle invasive bladder cancer
    Hartert, Marc
    Deppe, Claudia
    Fink, Ludger
    Kappes, Jutta
    JOURNAL OF CLINICAL TUBERCULOSIS AND OTHER MYCOBACTERIAL DISEASES, 2024, 35
  • [36] Intravesical BCG induces a trained immunity phenotype in patients with non-muscle invasive bladder cancer
    van Puffelen, J. H.
    Novakovic, B.
    Van Emst, L.
    Boormans, J. L.
    Oosterwijk, E.
    Van der Heijden, A. G.
    Netea, M. G.
    Joosten, L. A. B.
    Vermeulen, S. H.
    EUROPEAN UROLOGY, 2021, 79 : S615 - S616
  • [37] HRQOL IN PATIENTS UNDERWENT INTRAVESICAL INSTILLATION OF BCG OR MMC FOR NON-MUSCLE INVASIVE BLADDER CANCER
    Siracusano, Salvatore
    Silvestri, Tommaso
    Ciciliato, Stefano
    Toffoli, Laura
    Visalli, Francesco
    Di Cosmo, Giacomo
    Talamini, Renato
    JOURNAL OF UROLOGY, 2016, 195 (04): : E134 - E135
  • [38] S1605: Phase II trial of atezolizumab in BCG-unresponsive non-muscle invasive bladder cancer
    Singh, Parminder
    Catherine, Tangen
    Lerner, Seth P.
    McConkey, David
    Plets, Melissa
    Lucia, M. Scott
    Woods, Michael
    Bivalacqua, Trinity
    Kassouf, Wassim
    Bangs, Richard Carlton
    Thompson, Ian Murchie
    Black, Peter C.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [39] Analysis of urinary leukocytes during intravesical immunotherapy with BCG for non-muscle invasive bladder cancer
    Takeda, Yuji
    Kato, Tomoyuki
    Kurota, Yuta
    Ito, Hiromi
    Tsuchiya, Norihiko
    Asao, Hironobu
    CANCER SCIENCE, 2018, 109 : 978 - 978
  • [40] The Application of Nanomedicine in the Intravesical Instillation Therapy of Non-muscle Invasive Bladder Cancer
    Yu, Qing-song
    Gan, Zhi-hua
    ACTA POLYMERICA SINICA, 2023, 54 (01): : 1 - 13
12345